Quick answer: Buying a medical practice means acquiring an existing patient base, trained staff, active payer credentialing, and immediate cash flow instead of building all four from zero. The purchase price is rarely where deals go wrong. What decides the outcome is what you verify first: the quality of the earnings, how much of the revenue depends on the departing physician, and how long your own credentialing will take.
Most physicians are trained to evaluate a patient, not a balance sheet. So the first practice acquisition is usually approached the way a clinical problem is approached — carefully, thoroughly, and in the wrong order. The financial review comes last, after months of emotional investment in a particular practice, when walking away has become expensive.
The order matters more than the effort.
What you are actually buying
A practice purchase is a bundle of assets, and they are not equally valuable:
- The patient panel — the largest component of value in most primary care and pediatric acquisitions, and the one most sensitive to how the transition is handled.
- Payer contracts and credentialing — an asset only if it transfers. In many structures it does not, and you re-credential from scratch.
- The staff — a front-desk manager who has run the schedule for a decade is frequently the most underpriced asset in the deal.
- The lease and location — patients are loyal to a location more often than owners expect.
- Equipment and build-out — the easiest item to value and the least likely to determine whether the practice thrives.
- Goodwill — the residual, and the part that either survives the handover or evaporates during it.
The diligence that actually protects you
Ask for these before you ask about price:
- Three years of financials, normalized. Owner compensation, personal expenses run through the practice, and one-time items adjusted out. The reported number and the transferable number are rarely the same.
- Payer mix by percentage of collections. A practice that looks healthy on volume can be fragile on reimbursement. Concentration in one contract is a risk, not a feature.
- Panel health, not panel size. Active patients seen in the last eighteen months, new-patient rate, and attrition trend. A large inactive panel is a marketing cost, not an asset.
- Provider dependence. What share of collections is generated personally by the seller? The higher that share, the more of the purchase price is walking out the door at closing.
- Referral sources. If three physicians send most of the new patients, meet them before closing, not after.
- Compliance and records. HIPAA posture, EHR contract and transferability, open payer audits, malpractice history, and tail coverage arrangements.
Where acquisitions go wrong
Four failures account for most of the bad outcomes, and all four are visible in advance.
- Credentialing lag. Payer enrolment routinely runs 90 days or longer. Buyers who budget for a clean revenue handoff and get a three-month gap end up short on working capital in month two.
- Financing a price the appraisal will not support. A lender’s valuation is not a formality. An overpriced practice fails at the appraisal stage, after both sides have spent months and money.
- No transition plan. Patients and staff leave when the handover is abrupt. The seller’s presence for an agreed period is often worth more than a price concession.
- Skipping specialized counsel. Corporate practice of medicine rules, ownership structures, and non-compete enforceability vary by state and change the shape of the deal.
Questions worth asking the seller directly
Documents tell you what happened. These questions tell you why, and the answers are usually more revealing than the financials:
- Why are you selling, and why now? Retirement, burnout, relocation, and a declining panel produce very different deals. A seller who answers this without hesitation is generally a seller who has prepared.
- What would you fix if you were staying five more years? Sellers know exactly where the weaknesses are. Most will tell you if asked plainly.
- Which staff members are you worried about losing? The names in that answer are the people to meet before closing.
- What has changed in your payer contracts in the last three years? Reimbursement trends matter more than a single year’s collections.
- How long will you stay after closing, and in what role? Vague answers here are the leading indicator of a rough transition.
Where advisors fit
Healthcare business brokers and M&A advisors sit on one side of a transaction or the other, and the distinction matters to a buyer. A firm representing the seller owes its duty to the seller. That is not a criticism — it is the structure — but it means a buyer working with the listing side has no one holding the other end of the rope. Buy-side representation, or at minimum a healthcare-specific valuation of your own, closes that gap. Specialized advisors also see practices before they are publicly listed, which is where most quality transitions happen.
Strategic Medical Brokers represents sellers exclusively and maintains a buyer list for physicians searching in specific specialties and markets, so the two sides are never worked by the same person.
Start here
Before you look at a single listing, three things: an honest picture of what you can finance, a written list of the specialties and markets that fit your life, and a conversation with an advisor who has actually run a practice. Buying a medical practice is a better path than building for most physicians. It is only a better path when the diligence comes before the attachment.
When you’re ready, we’re here.
